Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

United Therapeutics Corporation
United Therapeutics Corporation A Delaware Corporation
United Therapeutics Corporation_20100114
  

United Therapeutics Corporation patents

Recent patent applications related to United Therapeutics Corporation. United Therapeutics Corporation is listed as an Agent/Assignee. Note: United Therapeutics Corporation may have other listings under different names/spellings. We're not affiliated with United Therapeutics Corporation, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | United Therapeutics Corporation-related inventors




Date United Therapeutics Corporation patents (updated weekly) - BOOKMARK this page
07/13/17Synthesis of intermediate for treprostinil production
06/29/17Process to prepare treprostinil, the active ingredient in remodulin®
06/08/17Synthesis of intermediates for producing prostacyclin derivatives
05/25/17Process to prepare treprostinil, the active ingredient in remodulin®
05/25/17Process to prepare treprostinil, the active ingredient in remodulin®
04/06/17Treprostinil formulations
03/16/17Salts of treprostinil
02/16/17Process for making beraprost
12/08/16Compounds and methods for delivery of prostacyclin analogs
10/06/16Method for purifying antibodies
09/08/16Dosage inhaler
06/30/16Method for purifying antibodies using pbs
05/26/16Treprostinil administration by inhalation
04/21/16Synthesis of intermediates for producing prostacyclin derivatives
03/10/16Synthesis of intermediate for treprostinil production
02/25/16Compounds and methods for delivery of prostacyclin analogs
02/04/16Compounds and methods for delivery of prostacyclin analogs
12/31/15Process to prepare treprostinil, the active ingredient in remodulin®
10/22/15Process to prepare treprostinil, the active ingredient in remodulin®
09/24/15Salts of treprostinil
09/17/15Compounds and methods for delivery of prostacyclin analogs
09/03/15Treatment of pulmonary arterial hypertension with mesenchymal stem cells
08/13/15Iminosugars and methods of treating viral diseases
08/06/15Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells
06/18/15Inhalation formulations of treprostinil
04/16/15Treprostinil production
01/01/15Compounds and methods for delivery of prostacyclin analogs
10/30/14Controlled release pharmaceutical formulations
09/25/14Process of making prostacyclin compounds with linker thiol and pegylated forms
09/18/14Solid forms of treprostinil
09/18/14Salts of treprostinil
07/10/14Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
07/10/14Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
01/16/14Treprostinil treatment for interstitial lung disease and asthma
12/26/13Synthesis of intermediate for treprostinil production
09/26/13Treatment for pulmonary hypertension
09/12/13Iminosugars and methods of treating viral diseases
08/01/13Combination therapy for treatment of viral infections
07/18/13Method of identifying therapies for pulmonary hypertension
06/13/13Iminosugars and methods of treating togaviral diseases
04/18/13Treprostinil treatment for interstitial lung disease and asthma
01/10/13Use of patterns in processing on mobile monitoring device and computer system
11/22/12Compounds and methods for delivery of prostacyclin analogs
11/08/12Process to prepare treprostinil, the active ingredient in remodulin®
09/06/12Synthesis of intermediate for treprostinil production
08/30/12Treprostinil administration by inhalation
08/02/12Treprostinil production
07/26/12Treprostinil production
05/24/12Treprostinil treatment for interstitial lung disease and asthma
01/12/12Combination therapies with cox-2 inhibitors and treprostinil
01/05/12Oral treatment of digital ischemic lesions
12/29/11Treprostinil production
09/15/11Treatment for pulmonary hypertension
07/28/11Long chain n-alkyl compounds and oxa-derivatives thereof
06/16/11Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
05/19/11Compounds and methods for delivery of prostacyclin analogs
04/21/11Use of treprostinil to treat neuropathic diabetic foot ulcers
02/24/11Sugar immunogens
11/11/10Solid formulations of prostacyclin analogs
06/03/10Long chain n-alkyl compounds and oxa-derivatives thereof
03/25/10Treprostinil administration using a metered dose inhaler
01/14/10Atrial fibrillation detection
07/16/09Combinatorial library approach to iminocyclitols with biological activity
06/25/09Process to prepare treprostinil, the active ingredient in remodulin
05/14/09Inhalation formulations of treprostinil
Patent Packs
03/26/09Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
02/05/09Combination therapy for pulmonary arterial hypertension
01/14/10Atrial fibrillation detection
09/02/10Cooperative processing with mobile monitoring device and computer system







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with United Therapeutics Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for United Therapeutics Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';